- Home
- BTDR vs BLTE Comparison
BTDR vs BLTE Comparison
Compare BTDR & BLTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BTDR
- BLTE
- Stock Information
- Founded
- BTDR 2021
- BLTE 2018
- Country
- BTDR Singapore
- BLTE United States
- Employees
- BTDR N/A
- BLTE N/A
- Industry
- BTDR EDP Services
- BLTE Biotechnology: Pharmaceutical Preparations
- Sector
- BTDR Technology
- BLTE Health Care
- Exchange
- BTDR Nasdaq
- BLTE Nasdaq
- Market Cap
- BTDR 2.0B
- BLTE 1.9B
- IPO Year
- BTDR N/A
- BLTE 2022
- Fundamental
- Price
- BTDR $14.12
- BLTE $61.10
- Analyst Decision
- BTDR Strong Buy
- BLTE Strong Buy
- Analyst Count
- BTDR 9
- BLTE 4
- Target Price
- BTDR $18.17
- BLTE $96.67
- AVG Volume (30 Days)
- BTDR 5.1M
- BLTE 29.7K
- Earning Date
- BTDR 05-15-2025
- BLTE 05-14-2025
- Dividend Yield
- BTDR N/A
- BLTE N/A
- EPS Growth
- BTDR N/A
- BLTE N/A
- EPS
- BTDR N/A
- BLTE N/A
- Revenue
- BTDR $349,782,000.00
- BLTE N/A
- Revenue This Year
- BTDR $69.87
- BLTE N/A
- Revenue Next Year
- BTDR $95.56
- BLTE N/A
- P/E Ratio
- BTDR N/A
- BLTE N/A
- Revenue Growth
- BTDR N/A
- BLTE N/A
- 52 Week Low
- BTDR $5.25
- BLTE $40.00
- 52 Week High
- BTDR $26.99
- BLTE $86.53
- Technical
- Relative Strength Index (RSI)
- BTDR 71.00
- BLTE 51.45
- Support Level
- BTDR $9.87
- BLTE $59.04
- Resistance Level
- BTDR $11.35
- BLTE $62.55
- Average True Range (ATR)
- BTDR 1.02
- BLTE 2.51
- MACD
- BTDR 0.56
- BLTE 0.32
- Stochastic Oscillator
- BTDR 92.83
- BLTE 74.06
About BTDR Bitdeer Technologies Group
Bitdeer Technologies Group is principally engaged in provision of digital asset mining services. Its majority business segments are: proprietary mining, cloud hash rate sharing and cloud hosting. The company operates five proprietary mining datacenters in the United States and Norway.
About BLTE Belite Bio Inc
Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.